GGrantIndex
Sort

51,570 grants matching autoimmune disease

RNA binding proteins in end-organ autoimmune pathology

$643,599
Sarah L. Gaffen · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI

Therapeutic mechanisms of iPSC-MSC derived extracellular vesicles on dry mouth caused by Sjorgren's syndrome or radiotherapy

$643,574
Fei Liu · Texas A&M University Health Science Ctr · R01 · FY2025 · DE

Development of a New Multiplexed Imaging Strategy for Immunoprofiling using Raman-Active Nanoparticles

$643,522
Cristina L. Zavaleta · University Of Southern California · R01 · FY2024 · CA

Immune reconstitution following autologous and allogeneic stem cell transplant

$643,479
Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

TrialNet: University of Florida Clinical Center and Network

$643,470
Desmond Arthur Schatz · University Of Florida · U01 · FY2010 · DK

Prenatal Tobacco Smoke, Genetic and Epigenetic Changes, and Respiratory Health

$643,423
Carrie Van Doren Breton · University Of Southern California · R01 · FY2013 · ES

Validation of Immunometabolic NLRX1 Therapeutics for IBD

$643,417
Andrew Leber · Biotherapeutics, Inc. · R44 · FY2021 · DK

TLR-Dependent Dendritic Cell Activation in SLE

$643,413
Ian R Rifkin · Boston University Medical Campus · P01 · FY2006 · AR

Neurosarcoidosis: Clinical Phenotype, Biomarkers and Immunopathogensis

$643,385
Carlos A Pardo-Villamizar · Johns Hopkins University · R01 · FY2024 · NS

Host's and microbiota's contribution to sexual dimorphism of autoimmunity

$643,338
Alexander V Chervonsky · University Of Chicago · R01 · FY2025 · AI

Apoptosis

$643,334
John A. Cidlowski · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

Defining the Targets and Function of Direct Trigeminal Sensory Innervation to Salivary Glands

$643,224
Isabelle M.a. Lombaert · University Of Michigan At Ann Arbor · R01 · FY2023 · DE

Autonomous Grippers in the Gastrointestinal Tract

$643,193
Florin Selaru · Johns Hopkins University · R01 · FY2025 · EB

Examining the Effects of Immulina to Increase Immune Resilience against Influenza Virus Infections

$643,143
Gailen D. Marshall · University Of Mississippi · U19 · FY2024 · AT

Rituximab Therapy in Patients with IPF

$643,011
Steven R Duncan · University Of Alabama At Birmingham · R01 · FY2014 · HL

T Cell Alternative p38 Activation Pathway

$642,994
Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions

$642,896
Emmanuel J Mignot · Stanford University · U01 · FY2022 · NS

Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis

$642,873
V Michael Holers · University Of Colorado Denver · U01 · FY2018 · AI

Vascular, Pulmonary and Renal Injury

$642,777
Michael A Gimbrone · Brigham And Women'S Hospital · T32 · FY2011 · HL

Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome

$642,750
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Predictive Biomarkers for disease activity and organ damage in patients with lupus

$642,740
Betty P. Tsao · Medical University Of South Carolina · R01 · FY2019 · AR

Neuroimmunotoxicology: autoimmunity, inflammation, age, environmental agents

$642,713
Gaylia Jean Harry · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES

Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD

$642,579
Stefanie Sarantopoulos · Duke University · R01 · FY2016 · HL

Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD

$642,579
Stefanie Sarantopoulos · Duke University · R01 · FY2019 · HL

Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD

$642,579
Stefanie Sarantopoulos · Duke University · R01 · FY2017 · HL